Dermal Fillers Market to Grow at a CAGR of 8.1% Over 2024 - 2032; Rising Trend of Male Individuals Opting for Dermal Fillers to Bolster Market Expansion

The global dermal fillers market size stood at USD 5.08 billion in 2023. The market is predicted to rise from USD 5.44 billion in 2024 to USD 10.16 billion by 2032, recording a CAGR of 8.1% from 2024 to 2032.

Fortune Business Insights™ presents this information in its report titled, “Dermal Fillers Market Size, Share & Industry Analysis, By Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (Methyl Methacrylate)), Fat Fillers, and Others), By Product (Biodegradable and Non-Biodegradable), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, and Others), By End-user (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others), and Regional Forecast, 2024-2032”.  

Dermal fillers are non-invasive cosmetic procedures that address issues, including facial lines, wrinkles, lip enhancement, restoration of lost volume, and acne scars. Increasing procedural volumes to improve facial features due to rising disposable income and rapid adoption of these procedures by males to enhance their appearances are fostering market expansion.

The COVID-19 pandemic adversely impacted market expansion owing to decreased production and limitations on import and export due to lockdown restrictions.

Increase in Product Introductions by Key Companies to Boost Market Growth

In February 2023, Galderma introduced Radiesse (+) Lidocaine injectable implants. They are specially made for deep injection (subdermal and supraperiosteal) to improve the contour of the jawline and tackle moderate to severe loss in adults aged 21 and above.

Rapid Adoption of Minimally Invasive Cosmetic Procedures to Propel Market Growth

Increasing demand for facial aesthetics is one of the most crucial market drivers. Individuals generally adopt easier and painless procedures for a youthful appearance and radiant face. The preference for minimally invasive cosmetic procedures is increasing due to risks associated with invasive surgeries that require additional time for recovery. Rising demand for minimally invasive aesthetic procedures is paving the way for filler product manufacturers. Increasing product offerings by key players to meet the demand for medical aesthetics are fueling the dermal fillers market growth.

In May 2023, Galderma introduced RESTYLANE EYELIGHT in Canada. It is a hyaluronic acid injectable dermal filler that assists in decreasing under-eye grooves caused by a lack of volume in the under-eye area. Such introductions boosted the increased demand for these procedures.

On the other hand, substantial costs related to these products are hampering market expansion.

JUVEDERM Collection Makes a Strong Foothold in the Market Due to Its Diverse Application Areas

The presence of both renowned corporations and start-ups is fueling market growth. ALLERGAN (AbbVie, Inc.) accounts for a dominant position in the market. This market dominance is attributed to the company's robust portfolio of dermal fillers, such as the JUVEDERM Collection of Hyaluronic Acid (HA) fillers. JUVEDERM Collection acquires a prominent position in the global dermal fillers industry due to its diverse application areas.

Notable Industry Development

• February 2022: Abbvie Inc. obtained FDA approval for JUVEDERM VOLBELLA XC for the improvisation of infraorbital hollow in adults over the age of 21.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/dermal-fillers-market-100939

List of the Companies Profiled in the Report:

• ALLERGAN (AbbVie Inc.) (U.S.)


• Revance Therapeutics, Inc. (U.S.)


• Merz Pharma (Germany)


• Galderma (Switzerland)


• Sinclair Pharma (U.K.)


• BIOPLUS CO., LTD. (South Korea)


• Bioxis Pharmaceuticals (France)


• SCULPT Luxury Dermal Fillers Ltd. (Czech Republic)


• DR. Korman (Israel)


• Prollenium Medical Technologies (Canada)


• Suneva Medical (U.S.)


• Anika Therapeutics, Inc. (U.S.)

Further Report Findings-

• The market in Asia Pacific was valued at USD 1.98 billion in 2023. Increasing awareness about cosmetic procedures is driving market growth in the region.


• Europe accounted for the second-highest dermal fillers market share. Growing preference for dermal filler procedures among individuals in key European countries and rising spending on research and development (R&D) are the key factors boosting market growth in the region.


• Based on material, the hyaluronic acid segment is set to dominate the market over the forecast period owing to the introduction of new products.


• On the basis of product, the biodegradable segment is expected to lead the market during the forecast period. Increasing availability of biodegradable fillers is driving segment expansion.

Table of Segmentation